About one-third to one-half of all antibiotics used in hospitals is for surgical prophylaxis; however, 30 to 90 percent of this use is inappropriate (Munckhof. Aust Prescr 2005; 28: 38-40). The Jordan Food and Drug Administration (JFDA) recently conducted a study in Jordanian hospitals that provided data on surgical antibiotic prophylaxis practices, including for cesarean section (JFDA, Rational Drug Use Department, May 2009). The study findings indicate that these practices can be improved. In the context of the JFDA’s study findings and recommendations, SPS is providing technical assistance to help strengthen practices regarding antibiotic prophylaxis for cesarean sections at selected hospitals in Jordan.
In April-May 2011, SPS collaborated with the Ministry of Health, Royal Medical Services, JFDA, and the participating hospitals’ leadership teams to conduct several workshops in Jordan that led to developing—
- Protocol and procedures for administering antibiotic prophylaxis for cesarean sections in each of the four participating hospitals
- A plan for implementing the protocols and procedures using an approach that is consistent with continuous quality improvement (CQI)
- Percentage of cesarean section cases in which the appropriate prophylactic antibiotic was administered
- Percentage of cesarean section cases in which the first dose of the prophylactic antibiotic was given at the appropriate time
- Percentage of cesarean section cases in which the appropriate number of doses of the prophylactic antibiotic was given
- Estimated value of avoided unnecessary antibiotic doses
Click here [PDF-1.09MB] to read the workshop presentation on current international evidence and recommendations on antibiotic prophylaxis for cesarean section.
Click here [PDF-2.64 MB] to read the presentation on CQI method to improve antibiotic prophylaxis in cesarean section.
Copyright © 2011 Management Sciences for Health, Inc. All rights reserved. Please address your comments to webchanges@msh.org.